Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor ...

A shortage of culturally diverse stem cell donors means many patients in Australia depend on overseas donors, but some can't ...

Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

The study uncovers mechanisms linking Down syndrome to leukemia, emphasizing the role of oxidative stress and genetic alterations in fetal blood development.

A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondriaIn ...

WATCH the moment a blood cancer survivor met the young stranger who provided the stem cell donation that saved her life.

A study found omitting a course of antibiotic prophylaxis was non-inferior to the routinely administering antibiotics in ...

Last November, longtime Claremont resident Lou Berrio was diagnosed with acute myeloid leukemia, a type of cancer that tricks ...

A new research paper titled "ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells" has been published in Oncotarget.

Inc. (Nasdaq: TSVT) today announced that the Company, in partnership with study sponsor Bristol Myers Squibb (BMS), will ...